Literature DB >> 8603540

Anti-DNA antibody derived from a systemic lupus erythematosus (SLE) patient forms histone-DNA-anti-DNA complexes that bind to rat glomeruli in vivo.

T Morioka1, Y Fujigaki, S R Batsford, R Woitas, T Oite, F Shimizu, A Vogt.   

Abstract

Histone can mediate the binding of both free DNA and DNA complexed to anti-DNA antibody to the glomerular capillary wall. We tested whether performed histone-DNA-anti-DNA immune complexes (IC) could bind to the glomerular capillary wall. The immune complex, generated with anti-DNA antibody derived from an SLE patient and excess of 125I-DNA followed by digestion with DNase, was mixed with histones. The complex containing 4 micrograms DNA was injected via the aorta into the left kidney of rats. At 15 min, 1-3% of the histone-DNA-anti-DNA antibody complex bound (measured as 125I-DNA), when histone was omitted less than 0-1% of the DNA-anti-DNA antibody complex bound. By immunofluorescence human immunoglobulins and histones, representing the IC, could be observed in a capillary pattern; but no complement deposition was detected. Electron microscopy revealed discrete, electron dense deposits in a subendothelial, subepithelial and mesangial localization at 15 min. These results provide direct evidence that antibodies from serum of SLE patients can form soluble histone-DNA-anti-DNA immune complexes that bind to the glomerular capillary wall in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603540      PMCID: PMC2200408          DOI: 10.1046/j.1365-2249.1996.d01-658.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  5 in total

1.  Physical and biological studies on DNA/anti-DNA immune complex formed in vitro.

Authors:  Y Gao; P Wang; A Tajima; M Matsumura
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

2.  Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies.

Authors:  D Villalta; N Bizzaro; S Platzgummer; A Antico; M Tampoia; L Camogliano; D Bassetti; M Pradella; A Piazza; F Manoni; R Tozzoli; E Tonutti
Journal:  Clin Rheumatol       Date:  2004-12-10       Impact factor: 2.980

Review 3.  Oxygen free radicals and systemic autoimmunity.

Authors:  H Ahsan; A Ali; R Ali
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  Clearing the complexity: immune complexes and their treatment in lupus nephritis.

Authors:  Catherine Toong; Stephen Adelstein; Tri Giang Phan
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-01-11

5.  Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden.

Authors:  Sahwa Elbagir; Azita Sohrabian; Amir I Elshafie; Elnour M Elagib; Nasr Eldeen A Mohammed; Musa A M Nur; Elisabet Svenungsson; Iva Gunnarsson; Johan Rönnelid
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.